Item 8.01 Other Events.

On December 11, 2020, Greenwich LifeSciences, Inc. (the "Company") announced the publication of a second poster for the GP2 Phase III clinical trial design for recurring breast cancer at the San Antonio Breast Cancer Symposium (SABCS) in a virtual format. A copy of the press release is attached hereto as Exhibit 99.1and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.




Exhibit No.                  Description

99.1            Press release dated December 11, 2020




  -2-

© Edgar Online, source Glimpses